Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Reproductive system and breast disorders – page 40

  • 960 clinical trials
  • 390 recruiting
  • 346 conditions
  • 28 countries

Conditions in this area

346 conditions with trials, the busiest first

Breast cancer170Prostate cancer102Ovarian cancer90Breast cancer metastatic84Triple negative breast cancer69Hormone receptor positive HER2 negative breast cancer62Hormone-refractory prostate cancer56Endometrial cancer53Prostate cancer metastatic48HER2 positive breast cancer42Hormone receptor positive breast cancer42Cervix carcinoma35Fallopian tube cancer30Breast cancer female27Non-small cell lung cancer25Infertility female22Hormone-dependent prostate cancer19Infertility18Ovarian cancer recurrent18Ovarian epithelial cancer18Colorectal cancer12Gastric cancer12Head and neck cancer12Malignant peritoneal neoplasm12+322

Clinical trials in Reproductive system and breast disorders

960 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

960 clinical trials

Triple negative breast cancer

Not yet recruiting

Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Swiss Group for Clinical Cancer Research

Prostate cancer

Not yet recruiting

Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Relugolix
  • Sponsor:Fondazione Radioterapia Oncologica Onlus

Menopausal symptoms

Not yet recruiting

Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Estradiol
  • Sponsor:Karolinska University Hospital

Prostate cancer

Not yet recruiting

Study on Prostate Cancer: Comparing Stereotactic Body Radiation Therapy Alone or with Triptorelin and Bicalutamide for Patients with Acinar Cell Prostatic Carcinoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

Benign prostatic hyperplasia

Not yet recruiting

Study on Antibiotic Treatment Before Surgery for Benign Prostate Hyperplasia: Fosfomycin Calcium, Bromhexine Hydrochloride, Sulfamethoxazole, and Trimethoprim

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin calcium
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Hormone receptor positive HER2 negative breast cancer

Not yet recruiting

Study on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Duloxetine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Prostate cancer metastatic+1

Not yet recruiting

Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Copper (64CU) chloride
  • Sponsor:A.C.O.M. Advanced Center Oncology Macerata S.r.l.

Polycystic ovarian syndrome

Not yet recruiting

Study on Metformin and Metformin Hydrochloride for Overweight Adults with Polycystic Ovary Syndrome

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Metformin
  • Sponsor:HUS-Yhtymae

Breast cancer metastatic+1

Not yet recruiting

Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Croatian Cooperative Group For Clinical Trial Research In Oncology

Breast cancer+2

Not yet recruiting

A study of Zr89-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab
  • Sponsor:Institut Jules Bordet

Bacterial prostatitis+1

Not yet recruiting

Study on Fosfomycin for Treating Acute Bacterial Prostatitis in Patients with Multidrug-Resistant E. coli

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin
  • Sponsor:Fundacio Assistencial De Mutua De Terrassa Fpc

Prostate cancer metastatic+1

Not yet recruiting

Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Copper (64CU) chloride
  • Sponsor:A.C.O.M. Advanced Center Oncology Macerata S.r.l.

Substances studied in this area

The therapies tested most often in Reproductive system and breast disorders trials.

Paclitaxel118 clinical trialsCarboplatin86 clinical trialsPembrolizumab76 clinical trialsLetrozole74 clinical trialsFulvestrant59 clinical trialsDocetaxel49 clinical trialsEnzalutamide49 clinical trialsExemestane47 clinical trialsAnastrozole45 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.